TENOSYNOVIAL GIANT CELL TUMOR

Clinical trials for TENOSYNOVIAL GIANT CELL TUMOR explained in plain language.

Never miss a new study

Get alerted when new TENOSYNOVIAL GIANT CELL TUMOR trials appear

Sign up with your email to follow new studies for TENOSYNOVIAL GIANT CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 5 Completed 1

New drug trial aims to shrink painful joint tumors

Disease control Not yet recruiting

This study is testing an oral drug called pimicotinib in Japanese patients with a rare, non-cancerous joint tumor called tenosynovial giant cell tumor (TGCT). The main goals are to see how well the drug is tolerated, how it moves through the body, and whether it can shrink the tu…

Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR

Phase: PHASE2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control

Last updated Apr 01, 2026 23:11 UTC

TENOSYNOVIAL GIANT CELL TUMOR

Get alerted when new TENOSYNOVIAL GIANT CELL TUMOR trials appear

New drug trial aims to shrink painful joint tumors